Literature DB >> 18272577

A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils.

Mark Duval1, Marshall R Posner, Lisa A Cavacini.   

Abstract

In addition to the direct neutralization of virus, there is a broader potential for antibody-mediated inhibition of human immunodeficiency virus (HIV) by targeting HIV to effector cells. We demonstrate here that a bispecific antibody incorporating a broadly reactive anti-gp41 antibody, F240, and an anti-IgA receptor (CD89) antibody is effective at directing neutrophils to destroy HIV. Not only are neutrophils the predominant type of white blood cells and very efficient at mediating cell cytotoxicity, they are relatively resistant to infection with HIV. Therefore, they represent a significant weapon against infection if they can be directed and armed to destroy HIV and infected cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272577      PMCID: PMC2293036          DOI: 10.1128/JVI.02499-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.

Authors:  G G Olinger; M Saifuddin; G T Spear
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.

Authors:  T W Baba; V Liska; R Hofmann-Lehmann; J Vlasak; W Xu; S Ayehunie; L A Cavacini; M R Posner; H Katinger; G Stiegler; B J Bernacky; T A Rizvi; R Schmidt; L R Hill; M E Keeling; Y Lu; J E Wright; T C Chou; R M Ruprecht
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue.

Authors:  R Hamre; I N Farstad; P Brandtzaeg; H C Morton
Journal:  Scand J Immunol       Date:  2003-06       Impact factor: 3.487

Review 5.  Neutrophil deficiency and dysfunction in HIV-infected patients.

Authors:  D L Pitrak
Journal:  Am J Health Syst Pharm       Date:  1999-12-15       Impact factor: 2.637

6.  Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells.

Authors:  K Sundarapandiyan; T Keler; D Behnke; A Engert; S Barth; B Matthey; Y M Deo; R F Graziano
Journal:  J Immunol Methods       Date:  2001-02-01       Impact factor: 2.303

7.  Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.

Authors:  Francisco J Hernandez-Ilizaliturri; Venkata Jupudy; Julie Ostberg; Ezogelin Oflazoglu; Amy Huberman; Elizabeth Repasky; Myron S Czuczman
Journal:  Clin Cancer Res       Date:  2003-12-01       Impact factor: 12.531

8.  Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques.

Authors:  Flavia Ferrantelli; Regina Hofmann-Lehmann; Robert A Rasmussen; Tao Wang; Weidong Xu; Pei-Lin Li; David C Montefiori; Lisa A Cavacini; Hermann Katinger; Gabriela Stiegler; Daniel C Anderson; Harold M McClure; Ruth M Ruprecht
Journal:  AIDS       Date:  2003-02-14       Impact factor: 4.177

9.  The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain.

Authors:  Luis R Miranda; Mark Duval; Heather Doherty; Michael S Seaman; Marshall R Posner; Lisa A Cavacini
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein.

Authors:  Paul J Tacken; Kevan L Hartshorn; Mitchell R White; Cees van Kooten; Jan G J van de Winkel; Ken B M Reid; Joseph J Batenburg
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

View more
  16 in total

Review 1.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

2.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

3.  A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.

Authors:  Leili Jia; Yuanyong Xu; Chuanfu Zhang; Yong Wang; Huihui Chong; Shaofu Qiu; Ligui Wang; Yanwei Zhong; Weijing Liu; Yansong Sun; Fei Qiao; Stephen Tomlinson; Hongbin Song; Yusen Zhou; Yuxian He
Journal:  Virol J       Date:  2010-06-29       Impact factor: 4.099

Review 4.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

5.  Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins.

Authors:  Antu K Dey; Kathryn B David; Min Lu; John P Moore
Journal:  Virology       Date:  2009-01-08       Impact factor: 3.616

6.  Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.

Authors:  Kara Jensen; Rafiq Nabi; Koen K A Van Rompay; Spencer Robichaux; Jeffrey D Lifson; Michael Piatak; William R Jacobs; Glenn Fennelly; Don Canfield; Katie R Mollan; Michael G Hudgens; Michelle H Larsen; Angela M Amedee; Pamela A Kozlowski; Kristina De Paris
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  Neutralization of HIV by milk expressed antibody.

Authors:  Xiaocong Yu; Daniel Pollock; Mark Duval; Christopher Lewis; Kristin Joseph; Harry Meade; Lisa Cavacini
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731

Review 8.  Fc receptor-mediated antiviral antibodies.

Authors:  Donald N Forthal; Christiane Moog
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

9.  Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8.

Authors:  Xiaocong Yu; Mark Duval; Christopher Lewis; Melissa A Gawron; Rijian Wang; Marshall R Posner; Lisa A Cavacini
Journal:  J Immunol       Date:  2012-11-26       Impact factor: 5.422

10.  Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction.

Authors:  Peter V Robinson; Cheng-Ting Tsai; Amber E de Groot; Julia L McKechnie; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2016-08-17       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.